ONE YEAR EXPERIENCE WITH INCLISIRAN IN AN ACADEMIC LIPID CLINIC:
Therapeutic Area: Pharmacologic Therapy Background: Real-world data examining inclisiran use in US clinical practice are limited. We report a one-year experience with inclisiran in an academic lipid clinic. Methods: Retrospective chart review of patients prescribed inclisiran since FDA approval in D...
Main Authors: | Tommy T. Chiou, BA, Kimberly Tomasi, RN, BSN, Pam R. Taub, MD, Michael J. Wilkinson, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | American Journal of Preventive Cardiology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666667723001083 |
Similar Items
-
Harnessing RNA Interference for Cholesterol Lowering: The Bench‐to‐Bedside Story of Inclisiran
by: Michael J. Wilkinson, et al.
Published: (2024-03-01) -
Lipid lowering with inclisiran: a real-world single-centre experience
by: Jaimini Cegla, et al.
Published: (2022-12-01) -
LIPID TRENDS ON DONOR DERIVED ATHEROSCLEROTIC DISEASE AND ALLOGRAFT VASCULOPATHY IN HEART TRANSPLANT RECIPIENTS AT A LARGE ACADEMIC CENTER
by: Antoinette S. Birs, MD, et al.
Published: (2023-09-01) -
Small Interfering Ribonucleic Acid as Lipid-Lowering Therapy: Inclisiran in Focus
by: Jelena Rakocevic, et al.
Published: (2023-03-01) -
Inclisiran: a new generation of lipid-lowering siRNA therapeutic
by: Yanzhen Zhang, et al.
Published: (2023-10-01)